期刊文献+

CD44v6、VEGF、CEA水平检测对良恶性胸腔积液鉴别的意义 被引量:3

THE DIAGNOSTIC VALUE OF CD44v6,VEGF and CEA IN DET ERMINATION of BENIGN or MALIGNANT PLEURAL EFFUSION
下载PDF
导出
摘要 目的探讨CD44v6、VEGF、CEA单项和联合检测对鉴别良恶性胸腔积液的价值。方法选取70名胸腔积液患者,其中良性疾病组患者35例,恶性疾病组患者35例。采用ELISA法检测胸腔积液CD44v6、VEGF、CEA水平。结果在恶性疾病组中,CD44v6、VEGF、CEA的平均检测值分别为(45.50±24.94)ng/m、l(458.66±194.26)pg/m l和(29.92±20.57)ng/m l,在良性疾病组中CD44v6、VEGF、CEA平均检测值分别为(13.64±10.75)ng/m、l(137.88±73.72)pg/m、l(10.56±9.33)ng/m。l在单项检测中CD44v6、VEGF、CEA的敏感度分别为85.7%、91.4%、80.0%,特异度分别为80.0%、85.7%、71.4%;在联合检测中,VEGF+CD44v6组的敏感度为81.4%,特异度为90.0%;CD44v6+CEA组敏感度为68.6%,特异度为91.4%;VEGF+CEA组的敏感度为72.9%,特异度为94.3%;VEGF+CD44v6+CEA组敏感度为62.9%,特异度为96.2%。结论恶性疾病组胸腔积液CD44v6、VEGF、CEA水平分别明显高于良性疾病组,差异有显著性。单项检测中,VEGF和CD44v6有较高的敏感度和特异度,而在联合检测中,以VEGF+CD44v6和VEGF+CEA的敏感度和特异度相对较高。 Objective To observe the diagnostic value of CD44v6,VEGF and CEA in determination of benign or malignant pleural effusion.Methods Among 70 patients with pleural effusion,35 patients suffered from benign disease and 35 patients suffered from malignant disease.The expressions of CD44v6,VEGF and CEA in pleural effusion were detected with ELISA technique.Results In the group of malignant diseases,the average value of CD44v6,VEGF and CEA were 45.50 ±24.94ng/ml,458.66±194.26pg/ml and(29.92±20.57) ng /ml,respectively.In the group of benign disease,the average value of CD44v6,VEGF and CEA were 13.64±10.75ng/ml,137.88±73.72pg/ml and 10.56±9.33ng/ml,respectively.In single determination,the sensitivity of CD44v6,VEGF,CEA were 85.7%,91.4% and 80%,respectively.The specificity were 80%,85.7% and 71.4%,respectively,In combined determination,the sensitivity of VEGF+ CD44v6 was 81.4%,and the specificity was 90.0%,The sensitivity of CEA +VEGF was 72.9% and the specificity was 94.3%,The sensitivity of CEA+ CD44v6 was 68.6%,the specificity was 91.4%,The sensitivity of VEGF+CD44v6+CEA was 62.9%,the specificity was 96.2%.Conclusion The value of CD44v6,VEGF and CEA in malignant disease group is higher than that in benign disease group.There showed significant difference.In single detection,VEGF and CD44v6 have higher sensitivity and specificity.In combined detection,the groups of VEGF + CD44v6 and VEGF+CEA have higher sensitivity and specificity.
出处 《青海医学院学报》 CAS 2008年第1期39-42,共4页 Journal of Qinghai Medical College
关键词 胸腔积液 CD44V6 VEGF CEA 联合检测 鉴别诊断 pleural effusion CD44v6 VEGF CEA differential diagnosis
  • 相关文献

参考文献6

二级参考文献31

  • 1郭瑞霞,郭长青,乔玉环.腺苷脱氨酶和抗结核抗体检测对鉴别卵巢癌腹水和结核性腹水的意义[J].医学临床研究,2004,21(6):622-624. 被引量:10
  • 2徐继宾.血清与胸腹水同时检测CEA对肿瘤的诊断意义[J].菏泽医学专科学校学报,1997,9(2):49-50. 被引量:3
  • 3Demkow U,Zielonka TM,Strzaowski J,et al.Diagnostic value of IgA antibody levels against 38 kDa mycobacterial antigen[J].Pneumonol Alergol Po1,1998,66(11-12).509-516.
  • 4何胜洪.胸腹水ADA测定方法及其在结核性胸腹炎诊断中的应用[J].中华医学检验杂志,1988,11:75-75.
  • 5Jimenez D,Diaz G,Peroz E,et al.Diagnostic value of adenosine deaminase in nontuberulous lymphocytin pleural effusions[J].Eur respire J,2003,21 (2):220-224.
  • 6Braunschweig R, Yan E Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination[J]. Diagn Cytopathol, 2001, 24(3): 174-180.
  • 7Motherby H, Nadjari B, Friegel P, et al. Diagnostic accuracy of effusion cytology[J]. Diagn Cytopathol, 1999,20(6): 350-357.
  • 8Zeimet AG, Widschwendter M, Uhl-Steidl M, et al. High serum levels of soluble CD44 variant isoform V5 are associated with favorable clinical outcome in ovarian cancer[J]. Br J Cancer, 1997,76(12): 1646-1651.
  • 9Peterson RM, Yu Q, Stamenkovic I, et al. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites[J]. Am J Pathol,2000,156(6):2159-2167.
  • 10Weidner N.Introtumor microvessel density as a prognostic factor in cancer[J].Am J Pathol,1995,147(1):9-19.

共引文献22

同被引文献35

  • 1张凌,熊建萍,钟陆行.荧光定量PCR法检测转移性大肠癌患者化疗前后外周血CEAmRNA的表达及临床意义[J].实用肿瘤杂志,2006,21(5):443-446. 被引量:7
  • 2王卫军,杨林瀛,卢云涛,姜瑞华,高丽华,薛承岩.端粒酶、DNA异倍体和糖链抗原19-9与癌胚抗原诊断与鉴别诊断良、恶性胸腔积液价值的比较[J].临床荟萃,2007,22(4):282-284. 被引量:14
  • 3钱东华,左梦华,李丹,马忠森.CEA,CA199,CYFRA21-1测定对癌性、结核性胸腔积液的鉴别诊断价值[J].中国老年学杂志,2007,27(4):356-357. 被引量:8
  • 4Porcel J,VivesM,Esquerda A,et a.l Use of Panel of Markers in Pleural Fluid for Differential Diagnosis of Benign and Malignant Ef-fusions.Chest,2004,126:1757-1763.
  • 5Bustin SA,BenesV,NolanT,eta.l Quantitative real-time RT-PCR-a perspective[J].JMolEndocrinol,2005;34(3):597-601.
  • 6ShitritD,Zingerman B,ShitritAB,et a.l Diagnostic value of CYFRA21-1,CEA,CA 19-9,CA 15-3,and CA 125 assays in pleural efusions:analysis of116 cases and review of the literature.Oncologist,2005,10(7):501-507.
  • 7Lee JH,Chan g JH.Diagnostic utility ofserum and pleural fluid carcincembryonic antigen,neuron-specific enolase,and cyto-keratin 19 fragments in patientswith efusions from primary lung cancer.Chest,2005,128(4):2298-2303.
  • 8Ando S,Suzuki M,Yamamoto N,et al.The prognostic value of both neuronspecific enolase(NSE) and Cyfra21-1 in small cell lung cancer[J].Anticancer Res,2004,24(3B):1941~1946.
  • 9Pujol JL,Boher JM,Grenier J,et al.Neuron specitic enolase and prognosis of non-small cell lung cancer:prospective study in 621 patients[J].LungCancer,2001,31(2-3):221~228.
  • 10Natio T,Ohtuka M,Lshikawa H,et al.Clinical signifcance of cytokinemeasurement of pleural effusion[J] ·Kekkakku,1997,72(3):565~572.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部